Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China

Publication date: Available online 9 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Zhiqiang Wang, Zhibo Zhang, Yong Li, Li Sun, DeZhen Peng, Danyu Du, Xian Zhang, Luwei Han, Liwen Zhao, Ligong Lu, Hongzhi Du, Shengtao Yuan, Meixiao Zhan
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research